Hyperfine, Inc, the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced two significant advancements highlighting the potential of its innovative MRI technology to expand dementia screening, enhance monitoring, and improve care. Globally, over 57 million people live with dementia, with Alzheimer’s disease accounting for 60–80% of

BD, a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.  The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical and clinical studies, including a device clinical study demonstrating excellent performance with 100% of st

Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter is the first catheter to incorporate CenTRX™ Technology, a unique 96-degree pre-shaped tip designed to center in the vessel, maximiz

HeartBeam, Inc, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has been awarded the Innovation Award in Remote Cardiac Diagnostics as part of the 2025 Medical Device Network Excellence Awards. The award honors HeartBeam’s groundbreaking, FDA-cleared electrocardiogram (ECG) technology that enables clinical-grade diagnostics for arrhythmia assessment outside of traditional healthcare settings, expanding acc

Carestream Health recently secured an agreement with Vietnam South East Asia Joint Stock Company (VISTACOM), a leading distributor of advanced medical equipment solutions in Vietnam. “We are honored to join into a partnership with a renowned, industry leader like Carestream,” said Mr. Long Nguyen, Business Director of Vistacom. “We’re looking forward to providing our customers with the most advanced, user-friendly imaging solutions available.”

Fangzhou Inc. a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity. Fangzhou's founder, chairman, and CEO Dr. Xie Fa

Autonomix Medical, Inc, a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,295,646 (the ‘646 patent), titled, “Smart Torquer and Methods for Using the Same.” The newly issued ‘646 patent relates to a smart torquer device designed to enhance the manipulation of elongated intravascular devices during minimally invasive procedures, while in

Octagos, one of the fastest-growing remote cardiac monitoring platforms, today announced its selection for the Microsoft for Startups Pegasus Program - an elite, invite-only initiative for high-growth startups advancing innovation in AI, healthcare, and cybersecurity. Octagos is one of the only companies in the cardiac remote monitoring industry to be chosen for the program, gaining access to Microsoft's global enterprise ecosystem, go-to-market experts, and Microsoft Azure'

MorningStar Laboratories, LLC, a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce the expansion of the SmartVascular Dx™ test (formally known as the PULS™ Cardiac Test) into southern states. We are excited to announce that we are now officially included in the Medicare fee schedule, which allows us to offer our national medical coverage. Furthermore, our strategic partnerships with Buckeye Health Plan and America&rsq

Hippocratic AI, the global leader and pioneer in generative AI healthcare agents, today announced a partnership with Sheba Medical Center, a global beacon of medical innovation and research ranked by Newsweek as one of the top ten hospitals in the world. The partnership brings together Hippocratic AI’s leading AI agent technology and Sheba’s internationally acclaimed ARC (Accelerate, Redesign, Collaborate) Innovation Center to deploy safe, effective, and scalable AI solutions that